Author

B. Klonjkowski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

A. Saint-Albin-Deliot· 2 shared C. Bourgon· 2 shared N. Meunier· 2 shared S. Le Poder· 2 shared A. Dogliani· 1 shared A. Donchet· 1 shared A. Fraysse· 1 shared A. Roussel· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Saint-Albin-Deliot

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals

S. Thebault, N. Lejal, A. Dogliani, A. Donchet, A. Urvoas, M. Valerio-Lepiniec, M. Lavie, C. Baronti, F. Touret, B. da Costa, C. Bourgon, A. Fraysse, A. Saint-Albin-Deliot, J. Morel, B. Klonjkowski, , B. Delmas

This paper identifies biosynthetic proteins (Reps) that bind the SARS-CoV-2 spike RBD and neutralize the virus, including variants, with high potency and stability.

bioRxiv · May 10, 2022Microbiology

Neutrophils initiate the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters

C. Bourgon, A. Saint-Albin-Deliot, O. Ando-Grard, B. Da-Costa, R. Domain, B. Korkmaz, B. Klonjkowski, S. Lepoder, N. Meunier

This study shows that neutrophils contribute to olfactory epithelium damage during SARS-CoV-2 infection in hamsters by releasing infected cells, promoting viral spread.

bioRxiv · Mar 15, 2022 · PreprintImmunology

Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels

E. Cecon, D. Fernandois, N. Renault, C. F. F. Coelho, J. Wenzel, C. Bedart, C. Izabelle, S. Gallet, S. Le Poder, B. Klonjkowski, M. Schwaninger, V. PREVOT, J. Dam, R. Jockers

This study shows melatonin and its derivatives prevent SARS-CoV-2 brain entry and reduce cerebral damage in a mouse model.

bioRxiv · Dec 30, 2021Pharmacology & Toxicology